F3 and neoplasm: These changes reflect enhancement of both the initiation and amplification phases of coagulation, likely driven by tumor-associated procoagulant factors, such as tissue factor expression and subsequent activation of factor VII [31] and inflammatory cytokines [32], in dogs with cardiac tumors [33].